A small group of APL researchers, in collaboration with physicians from the Johns Hopkins Scleroderma Center in Baltimore, developed and recently completed initial trials for a miniature device to help physicians characterize Raynaud’s disease and measure treatment effectiveness.
“The Ambulatory Raynaud’s Monitor is a tiny, Band-Aid-like device that enables physicians to objectively characterize a patient’s condition, determine its severity and measure symptoms in real time,” says Dr. Frederick Wigley, director of the Hopkins Scleroderma Center and one of the country’s leading scleroderma experts, who asked the Johns Hopkins University Applied Physics Laboratory (APL), in Laurel, Md., to develop the device after reading about APL’s work developing miniature devices for spacecraft. “Until now, Raynaud’s research has been crippled without such a device.”
The small, low-cost monitor wraps around a patient’s finger and is secured with a bandage or medical tape. It contains two sensors that alternately record skin and ambient temperatures – indicators of surface blood flow – every 36 seconds. Interactive controls permit a patient to record the date and time of a suspected Raynaud’s attack. A week’s data is held by the monitor’s electronics and is retained even if the device’s power is unexpectedly interrupted.
Physicians can easily download data into a computer or PDA (personal digital assistant). Software developed by APL enables physicians to quickly and easily display and plot data, which could be done during a patient’s appointment to provide real-time feedback. The monitoring system’s batteries store enough energy to operate for several months, and devices can be cleaned and reinitialized for use with multiple patients.
Triggered by cold temperatures or stress, Raynaud’s is characterized by numbness and coldness in the fingers, toes, ears and/or nose when blood vessels in those areas constrict during attacks. Insufficient blood flow near the skin’s surface also causes patients to experience skin color changes and varying levels of discomfort. Limited blood flow to the extremities can potentially lead to permanent loss of function. Raynaud’s can occur on its own, or be secondary to another condition, such as auto-immune disorders like scleroderma or lupus.
The device recently underwent initial testing on patients with Raynaud’s being treated at the Johns Hopkins Medical Institutions. Patients wore a monitor for one week in their homes, pressing an “event button” on the device to indicate when a Raynaud’s event was occurring. The data – processed by APL engineers and evaluated by JHMI physicians – indicates Raynaud’s events can be successfully identified. Patients said the devices are comfortable and easy to use. “The data from this preliminary study suggests that the monitor can help scientists and physicians learn more about Raynaud’s phenomenon and help investigators evaluate the effectiveness of drugs being developed to treat this disease,” says APL’s Binh Le, one of the inventors of the device.
Based on initial data, APL researchers have enhanced the monitor’s design and are gearing up for the next round of trials at JHMI later this winter.
In addition to monitoring Raynaud’s patients, this platform technology could be used for an array of other medical or monitoring applications. The monitor could be modified to measure skin temperature of patients at risk for developing cardiovascular disease by tracking endothelial function (how small blood vessels regulate local blood flow to the tissues). Measuring skin temperature in various real-life situations may provide a noninvasive method to determine vascular responses in health and in various disease states.
With appropriate modifications, this monitoring system could also be used to track other physiological parameters, such as pulse rate and blood pressure, and transmit the information to remote call centers. Athletes, for example, could wear it to help measure their physiological performance throughout exercise routines.
Kristi Marren | EurekAlert!
Basque researchers turn light upside down
23.02.2018 | Elhuyar Fundazioa
Attoseconds break into atomic interior
23.02.2018 | Max-Planck-Institut für Quantenoptik
A newly developed laser technology has enabled physicists in the Laboratory for Attosecond Physics (jointly run by LMU Munich and the Max Planck Institute of Quantum Optics) to generate attosecond bursts of high-energy photons of unprecedented intensity. This has made it possible to observe the interaction of multiple photons in a single such pulse with electrons in the inner orbital shell of an atom.
In order to observe the ultrafast electron motion in the inner shells of atoms with short light pulses, the pulses must not only be ultrashort, but very...
A group of researchers led by Andrea Cavalleri at the Max Planck Institute for Structure and Dynamics of Matter (MPSD) in Hamburg has demonstrated a new method enabling precise measurements of the interatomic forces that hold crystalline solids together. The paper Probing the Interatomic Potential of Solids by Strong-Field Nonlinear Phononics, published online in Nature, explains how a terahertz-frequency laser pulse can drive very large deformations of the crystal.
By measuring the highly unusual atomic trajectories under extreme electromagnetic transients, the MPSD group could reconstruct how rigid the atomic bonds are...
Quantum computers may one day solve algorithmic problems which even the biggest supercomputers today can’t manage. But how do you test a quantum computer to...
For the first time, a team of researchers at the Max-Planck Institute (MPI) for Polymer Research in Mainz, Germany, has succeeded in making an integrated circuit (IC) from just a monolayer of a semiconducting polymer via a bottom-up, self-assembly approach.
In the self-assembly process, the semiconducting polymer arranges itself into an ordered monolayer in a transistor. The transistors are binary switches used...
Breakthrough provides a new concept of the design of molecular motors, sensors and electricity generators at nanoscale
Researchers from the Institute of Organic Chemistry and Biochemistry of the CAS (IOCB Prague), Institute of Physics of the CAS (IP CAS) and Palacký University...
15.02.2018 | Event News
13.02.2018 | Event News
12.02.2018 | Event News
23.02.2018 | Physics and Astronomy
23.02.2018 | Health and Medicine
23.02.2018 | Physics and Astronomy